{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:10:35Z","timestamp":1794305435350,"version":"4.9.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijcard.2024.132667","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T23:26:59Z","timestamp":1729553219000},"page":"132667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical reality and challenges with familial hypercholesterolemia patients' management. 2024 results from the Regional Center for Rare Diseases (RCRD) Registry in Poland"],"prefix":"10.1016","volume":"419","author":[{"given":"Joanna","family":"Lewek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Sosnowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Starostecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Konopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Gach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Adach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Mierczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Bielecka-D\u0105browa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcard.2024.132667_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11883-014-0482-5","article-title":"Familial hypercholesterolemia\u2014epidemiology, diagnosis, and screening","volume":"17","author":"Singh","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"issue":"22","key":"10.1016\/j.ijcard.2024.132667_bb0010","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of Familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ijcard.2024.132667_bb0015","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia","volume":"75","author":"Beheshti","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132667_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2019.103831","article-title":"Familial hypercholesterolemia: a complex genetic disease with variable phenotypes","volume":"63","author":"Di Taranto","year":"2020","journal-title":"Eur. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132667_bb0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tcm.2020.03.004","article-title":"Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels","volume":"31","author":"Bianconi","year":"2021","journal-title":"Trends Cardiovasc Med."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132667_bb0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am. J. Cardiol."},{"issue":"6807","key":"10.1016\/j.ijcard.2024.132667_bb0045","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Scientific steering committee on behalf of the Simon Broome register group","volume":"303","author":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","year":"1991","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132667_bb0050","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2014.12.034","article-title":"Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)","volume":"238","author":"Weng","year":"2015","journal-title":"Atherosclerosis"},{"issue":"36","key":"10.1016\/j.ijcard.2024.132667_bb0055","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2024.132667_bb0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132667_bb0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5114\/aoms\/183522","article-title":"Recommendations of the experts of the polish cardiac society (PCS) and the polish lipid association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels","volume":"20","author":"Sosnowska","year":"2024","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132667_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/aoms.2017.64712","article-title":"PoLA\/CFPiP\/PCS guidelines for the Management of Dyslipidaemias for family physicians 2016","volume":"13","author":"Banach","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ijcard.2024.132667_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2019.06.899","article-title":"The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the polish tertiary Centre: results from the TERCET registry with 19,781 individuals","volume":"288","author":"Dyrbu\u015b","year":"2019","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132667_bb0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12944-020-01335-2","article-title":"\u201cApple does not fall far from the tree\u201d \u2013 subclinical atherosclerosis in children with familial hypercholesterolemia","volume":"19","author":"Podg\u00f3rski","year":"2020","journal-title":"Lipids Health Dis."},{"issue":"10312","key":"10.1016\/j.ijcard.2024.132667_bb0085","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(21)01122-3","article-title":"Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia studies collaboration (FHSC)","volume":"398","author":"Vallejo-Vaz","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2024.132667_bb0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"290","author":"Mach","year":"2019","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ijcard.2024.132667_bb0095","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.5114\/aoms\/141941","article-title":"PoLA\/CFPiP\/PCS\/PSLD\/PSD\/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021","volume":"17","author":"Banach","year":"2021","journal-title":"Arch. Med. Sci."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132667_bb0100","first-page":"357","article-title":"2024 guidelines of the polish Society of Laboratory Diagnostics and the polish lipid association on laboratory diagnostics of lipid metabolism disorders","volume":"20","author":"Solnica","year":"2024","journal-title":"Arch. Med. Sci."},{"issue":"9","key":"10.1016\/j.ijcard.2024.132667_bb0105","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132667_bb0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.atherosclerosis.2018.08.008","article-title":"Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: results of the PLANET registry","volume":"277","author":"Vrablik","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132667_bb0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-511X-10-94","article-title":"Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial hypercholesterolemia longitudinal cohort study (SAFEHEART)","volume":"10","author":"Mata","year":"2011","journal-title":"Lipids Health Dis."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132667_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251560","article-title":"Familial hypercholesterolemia in the Arabian Gulf region: Clinical results of the Gulf FH Registry. Cheng X, editor","volume":"16","author":"Alhabib","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132667_bb0125","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacl.2020.12.001","article-title":"Familial hypercholesterolemia in Mexico: initial insights from the national registry","volume":"15","author":"Mehta","year":"2021","journal-title":"J. Clin. Lipidol."},{"issue":"45","key":"10.1016\/j.ijcard.2024.132667_bb0130","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132667_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.574474","article-title":"Genetics of Familial hypercholesterolemia: new insights","volume":"11","author":"Vrablik","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.ijcard.2024.132667_bb0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2021.01.008","article-title":"Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries","volume":"319","author":"Futema","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2024.132667_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosissup.2017.07.002","article-title":"Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study","volume":"29","author":"Pirillo","year":"2017","journal-title":"Atheroscler. Suppl."},{"issue":"24","key":"10.1016\/j.ijcard.2024.132667_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and treatment of heterozygous familial hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2024.132667_bb0155","series-title":"A Report of a WHO Consultation","author":"Familial hypercholesterolaemia","year":"1998"},{"issue":"nov11 1","key":"10.1016\/j.ijcard.2024.132667_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ijcard.2024.132667_bb0165","doi-asserted-by":"crossref","first-page":"639","DOI":"10.5551\/jat.62773","article-title":"Genetic analysis in a Taiwanese cohort of 750 index patients with clinically diagnosed Familial hypercholesterolemia","volume":"29","author":"Huang","year":"2022","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.ijcard.2024.132667_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2017.06.764","article-title":"Characterization of Italian patients with familial hypercholesterolemia: the lipigen study","volume":"263","author":"Casula","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2024.132667_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/9913969","article-title":"Familial hypercholesterolemia (FH) in Iran: findings from the four-year FH registry. Jauhiainen M, editor","volume":"2021","author":"Vaseghi","year":"2021","journal-title":"J. Lipids."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132667_bb0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1515\/CCLM.2008.135","article-title":"Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing","volume":"46","author":"Starr","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ijcard.2024.132667_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105499","article-title":"Optimal use of lipid-lowering therapy after acute coronary syndromes: a position paper endorsed by the international lipid expert panel (ILEP)","volume":"166","author":"Banach","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"45","key":"10.1016\/j.ijcard.2024.132667_bb0195","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1093\/eurheartj\/ehad446","article-title":"Eliminating atherosclerotic cardiovascular disease residual risk","volume":"44","author":"Makover","year":"2023","journal-title":"Eur. Heart J."},{"issue":"10421","key":"10.1016\/j.ijcard.2024.132667_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(23)01842-1","article-title":"Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2024.132667_bb0205","series-title":"Management of Children with Heterozygous Familial Hypercholesterolemia Worldwide: A Meta-Analysis","author":"Byty\u00e7i","year":"2024"},{"issue":"19","key":"10.1016\/j.ijcard.2024.132667_bb0210","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.3390\/jcm10194302","article-title":"Clinical features of familial hypercholesterolemia in children and adults in EAS-FHSC regional center for rare diseases in Poland","volume":"10","author":"Lewek","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132667_bb0215","first-page":"1429","article-title":"2022: the year in cardiovascular disease - the year of upfront lipid lowering combination therapy","volume":"18","author":"Banach","year":"2022","journal-title":"Arch. Med. Sci."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132667_bb0220","first-page":"1602","article-title":"Endorsed by the International Lipid Expert Panel (ILEP). 2023: the year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?","volume":"19","author":"Banach","year":"2023","journal-title":"Arch. Med. Sci."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324012890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324012890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T16:29:07Z","timestamp":1736526547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324012890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":41,"alternative-id":["S0167527324012890"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132667","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical reality and challenges with familial hypercholesterolemia patients' management. 2024 results from the Regional Center for Rare Diseases (RCRD) Registry in Poland","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"132667"}}